- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
15 result(s) found for: Stratified Sampling.
Displaying page 1 of 1.
EudraCT Number: 2006-005006-31 | Sponsor Protocol Number: EML053774_002 | Start Date*: 2007-04-03 |
Sponsor Name:Merck Sante France | ||
Full Title: A randomized, stratified on age, parallel group design study to investigate the safety, tolerability and pharmacokinetics after a 60 minutes application of 4% lidocaine cream compared to EMLA® crea... | ||
Medical condition: Topical anesthesia of healthy skin before venous or subcutaneous puncture, before superficial cutaneous instrumental surgery or laser beam (tattoo or cutaneousangioma) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002426-28 | Sponsor Protocol Number: 81896-PREDICTAM | Start Date*: 2022-11-14 |
Sponsor Name:Erasmus MC Cancer Institute | ||
Full Title: Predicting an accurate tamoxifen dose: a feasibility study in patients with hormone positive breast cancer | ||
Medical condition: Hormone positive breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005497-28 | Sponsor Protocol Number: PedMic | Start Date*: 2013-09-27 |
Sponsor Name:Erasmus MC - Sophia | ||
Full Title: Pediatric Microdosing: elucidating age-related changes in oral absorption | ||
Medical condition: Age-related changes in intestinal drug metabolism in children | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003353-41 | Sponsor Protocol Number: 0627 | Start Date*: 2018-07-05 |
Sponsor Name:University of Leicester | ||
Full Title: Mesothelioma Stratified Therapy (MiST): A stratified multi-arm phase IIa clinical trial to enable accelerated evaluation of targeted therapies for relapsed malignant mesothelioma. | ||
Medical condition: Malignant Mesothelioma (MM) - pleural and peritoneal | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006626-26 | Sponsor Protocol Number: OSI3364g | Start Date*: 2007-07-18 | |||||||||||
Sponsor Name:Genentech, Inc. | |||||||||||||
Full Title: A Phase III, Multicenter, Placebo-Controlled, Double-Blind, Randomized Clinical Trial to Evaluate the Efficacy of Bevacizumab in Combination with Tarceva (erlotinib) Compared With Tarceva Alone For... | |||||||||||||
Medical condition: Non-small-cell-lung-cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) BG (Prematurely Ended) SE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011182-86 | Sponsor Protocol Number: BLX883-204 | Start Date*: 2009-07-24 | |||||||||||
Sponsor Name:Biolex Therapeutics, Inc | |||||||||||||
Full Title: 480 Study: Phase 2b Open-label, Randomized Study in Treatment Naïve Subjects with HCV Genotype 1 to Compare the Efficacy, Safety, and Tolerability of the 480 µg Dose of Locteron™ Plus Ribavirin ... | |||||||||||||
Medical condition: Approximately 72 subjects with chronic hepatitis C (treatment naive, genotype 1) will be included in a 12 week open label randomized trial with 2 panels (approximately 40 subjects in PANEL A and ap... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012013-22 | Sponsor Protocol Number: BILA-3009/PED | Start Date*: 2009-12-09 | ||||||||||||||||
Sponsor Name:FAES FARMA S.A. | ||||||||||||||||||
Full Title: A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children from 2 to <12 Years of age with Allergic Rhinoconjunctivitis or Chronic Ur... | ||||||||||||||||||
Medical condition: Allergic Rhinoconjunctivitis and chronic urticaria | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-006312-31 | Sponsor Protocol Number: D3610C00002 | Start Date*: 2012-07-20 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase I/II, Multicentre, Study Comprising a Safety Run-In of AZD5363 when Combined with Paclitaxel in Patients with Advanced or Metastatic Breast Cancer; Followed by a Randomised Expansion of AZD... | ||
Medical condition: Advanced or metastatic breast cancer, ER+ve advanced or metastatic breast cancer, safety and tolerability, pharmacokinetics, pharmacodynamics, tumour response, PIK3CA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001818-14 | Sponsor Protocol Number: RELATE-TRD | Start Date*: 2013-12-20 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: RELATE and PREDICT TRD A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminer... | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001924-37 | Sponsor Protocol Number: D3250C00072 | Start Date*: 2020-01-07 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: SHAMAL: A Multicentre, Randomised, Open-Label, Parallel-Group, Active-Controlled, Phase IV Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever T... | |||||||||||||
Medical condition: Severe eosinophilic asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) FR (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019544-39 | Sponsor Protocol Number: 20090072 | Start Date*: 2010-10-04 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s Disease | |||||||||||||
Medical condition: Crohn’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) NL (Prematurely Ended) ES (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004863-35 | Sponsor Protocol Number: FMG-MM03/NMSG#23/15 | Start Date*: 2016-08-01 | |||||||||||
Sponsor Name:Hospital District of Helsinki and Uusimaa/Helsinki University Hospital HUS | |||||||||||||
Full Title: A prospective phase II study to assess the minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible patients | |||||||||||||
Medical condition: Multiple myeloma newly diagnosed transplant-eligible patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) NO (Ongoing) SE (Ongoing) LT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014696-52 | Sponsor Protocol Number: 17P-ES-003 | Start Date*: 2009-12-31 | |||||||||||
Sponsor Name:AMAG Pharma USA Inc. | |||||||||||||
Full Title: A PHASE 3B, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML, VERSUS VEHICLE FOR THE PREVENTION OF PRETERM BIRTH IN WOMEN WITH A PREVIOUS SINGLETON ... | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) IT (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001755-72 | Sponsor Protocol Number: GBG88 | Start Date*: 2016-11-22 | |||||||||||
Sponsor Name:German Breast Group | |||||||||||||
Full Title: Investigating Denosumab as an add-on to neoadjuvant chemotherapy in RANK/L-positive or RANK/L-negative primary breast cancer and two different nab-Paclitaxel schedules in a 2x2 factorial design (Ge... | |||||||||||||
Medical condition: Patients with early breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004643-80 | Sponsor Protocol Number: DS1062-A-U301 | Start Date*: 2021-03-10 | |||||||||||
Sponsor Name:Daiichi Sankyo, Inc. | |||||||||||||
Full Title: Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer without Actionable Genomic Alterations | |||||||||||||
Medical condition: Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) HU (Completed) DE (Ongoing) BE (Ongoing) NL (Ongoing) CZ (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.